Clinical trials show progress in migraine frequency, skin cancer prevention
-
3:07
’It’s pretty cool’: Army veteran Timothy Jach serves community...
-
4:03
The Christmas ’Kooky Cooky House’ lives on as a replica now...
-
5:44
’It’s been an amazing ride’: WKLH-FM’s Dave Luczak looks...
-
3:57
’I just find a lot of joy in it’: Wisconsin’s Bryce Ruland...
-
3:47
’It just makes me happy to know that there is still good people...
-
1:28
Silver Lake
-
5:42
New charges in 2020 fake elector scheme
-
1:48
Big Brothers Big Sisters hosts 1st annual Winter Wonderland Holiday...
-
0:38
2 men fell through the ice at inland lakes in separate incidents...
-
1:26
’It’s a nightmare’: Woman and 2 dogs found dead in West...
-
1:50
Schlesinger’s Saturday Showcase (12/14)...Lots of holiday ideas,...
-
3:05
Tricky travel for some later Saturday afternoon through the evening
MILWAUKEE (CBS 58) -- Clinical research studies are aiming to shed new light on the treatment of migraines and skin cancer. One investigates the potential use of a heart device to reduce migraines, while the other seeks to determine the optimal excision size in melanoma treatment.
Dr. Nina Garlie, Vice President of Clinical Trials Research at Aurora Health Care joined us on Thursday, May 25 to discuss these studies.
As part of the National Migraine and Headache Awareness Month in June, Dr. Garlie discussed the link between a particular heart condition and the frequency of migraines.
Also, with the advent of summer and the increased need for skin protection, she also elaborated on a clinical trial addressing skin cancer treatment specifics.
To learn more about the clinical trials and medical research conducted by Aurora Health Care, visit AAH.org/Research.